StockData
CNBX Pharmaceuticals Inc. logo

CNBX Pharmaceuticals Inc. (CNBX) stock

CNBXOTCPharmaceutical PreparationsFiscal year ends August 31
Financials through Q3 FY2026, quarter ended May 31, 2026Last filing: 10-Q on Jun 24, 2026Score 0/30
$0.00+0.00 (0.00%)

Close on Oct 19, 2026Market cap $197.79KP/E –Yield –

CNBX Pharmaceuticals cash

Cash and short-term investments held at the end of each period.

CNBX Pharmaceuticals's cash was $9.49K at May 31, 2026. For fiscal 2025 it was $15.11K, down 42.8% from the year before. Over ten years it grew -5.0% a year on average. The highest annual figure on record is $3.52M in fiscal 2019.

Annual cash

PeriodPeriod endValueChange
FY2025Aug 31, 2025$15.11K-42.8%
FY2024Aug 31, 2024$26.42K-79.6%
FY2023Aug 31, 2023$129.70K+10.4%
FY2022Aug 31, 2022$117.52K-91.5%
FY2021Aug 31, 2021$1.39M+78.3%
FY2020Aug 31, 2020$777.61K-77.9%
FY2019Aug 31, 2019$3.52M+152.8%
FY2018Aug 31, 2018$1.39M0.0%
FY2017Aug 31, 2017$1.39M+7186.1%
FY2016Aug 31, 2016$19.13K-24.2%
FY2015Aug 31, 2015$25.23K-74.5%
FY2014Aug 31, 2014$98.77K–
FY2013Aug 31, 2013$0–
FY2012Aug 31, 2012$0–
FY2011Aug 31, 2011$0-100.0%
FY2009Aug 31, 2009$177.74K–

Quarterly cash

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q3 FY2026CQ2 2026May 31, 2026$9.49K-30.5%
Q2 FY2026CQ1 2026Feb 28, 2026$12.15K-73.4%
Q1 FY2026CQ4 2025Nov 30, 2025$7.70K-55.6%
Q4 FY2025CQ3 2025Aug 31, 2025$15.11K-42.8%
Q3 FY2025CQ2 2025May 31, 2025$13.65K-81.4%
Q2 FY2025CQ1 2025Feb 28, 2025$45.68K+23.0%
Q1 FY2025CQ4 2024Nov 30, 2024$17.34K-78.8%
Q4 FY2024CQ3 2024Aug 31, 2024$26.42K-79.6%
Q3 FY2024CQ2 2024May 31, 2024$73.41K+66.3%
Q2 FY2024CQ1 2024Feb 29, 2024$37.14K-22.2%
Q1 FY2024CQ4 2023Nov 30, 2023$81.65K+278.0%
Q4 FY2023CQ3 2023Aug 31, 2023$129.70K+10.4%
Q3 FY2023CQ2 2023May 31, 2023$44.15K-54.1%
Q2 FY2023CQ1 2023Feb 28, 2023$47.75K-79.4%
Q1 FY2023CQ4 2022Nov 30, 2022$21.60K-97.3%
Q4 FY2022CQ3 2022Aug 31, 2022$117.52K-91.5%
Q3 FY2022CQ2 2022May 31, 2022$96.28K-95.2%
Q2 FY2022CQ1 2022Feb 28, 2022$231.64K-82.6%
Q1 FY2022CQ4 2021Nov 30, 2021$786.41K+327.3%
Q4 FY2021CQ3 2021Aug 31, 2021$1.39M+78.3%
Q3 FY2021CQ2 2021May 31, 2021$1.99M+455.4%
Q2 FY2021CQ1 2021Feb 28, 2021$1.33M+127.3%
Q1 FY2021CQ4 2020Nov 30, 2020$184.03K-42.4%
Q4 FY2020CQ3 2020Aug 31, 2020$777.61K-77.9%
Q3 FY2020CQ2 2020May 31, 2020$357.63K-27.5%
Q2 FY2020CQ1 2020Feb 29, 2020$586.97K-88.6%
Q1 FY2020CQ4 2019Nov 30, 2019$319.34K-95.1%
Q4 FY2019CQ3 2019Aug 31, 2019$3.52M+152.8%
Q3 FY2019CQ2 2019May 31, 2019$493.50K-77.7%
Q2 FY2019CQ1 2019Feb 28, 2019$5.17M+80.4%
Q1 FY2019CQ4 2018Nov 30, 2018$6.58M+127.8%
Q4 FY2018CQ3 2018Aug 31, 2018$1.39M0.0%
Q3 FY2018CQ2 2018May 31, 2018$2.22M-30.6%
Q2 FY2018CQ1 2018Feb 28, 2018$2.86M+405.0%
Q1 FY2018CQ4 2017Nov 30, 2017$2.89M+938.4%
Q4 FY2017CQ3 2017Aug 31, 2017$1.39M+7186.1%
Q3 FY2017CQ2 2017May 31, 2017$3.19M–
Q2 FY2017CQ1 2017Feb 28, 2017$567.22K–
Q1 FY2017CQ4 2016Nov 30, 2016$278.15K–
Q4 FY2016CQ3 2016Aug 31, 2016$19.13K–

More CNBX Pharmaceuticals figures

See a number that looks wrong?